Osterman appointed chair of mCODE executive committee
Oct. 20, 2022—Vanderbilt's Travis Osterman, DO, MS, has been appointed chair of the executive committee for the Minimal Common Data Elements (mCODE) initiative.
Policy, resources crucial for lung cancer screening: study
Sep. 29, 2022—Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.
Conquer Cancer awards given to five hematology-oncology fellows
May. 26, 2022—Five Vanderbilt University Medical Center hematology and oncology fellows will receive awards from Conquer Cancer, the ASCO Foundation, during the 2022 American Society of Clinical Oncology Annual Meeting in Chicago, June 3-7.
Improving care for gynecologic cancer
Mar. 15, 2022—To reduce risk of deep vein thrombosis in patients being treated for gynecologic cancer, Vanderbilt researchers recommend that providers use Khorana scores and provide prophylactic treatment according to clinical guidelines.
Vanderbilt researchers present new data on clinical trials at ASCO 2021
May. 26, 2021—Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year.
ASCO press program highlights COVID-19 outcomes in lung cancer patients
May. 26, 2020—People with thoracic cancers sickened by COVID-19 were especially vulnerable to deaths with a 35% mortality rate, according to early results from TERAVOLT, a global consortium that tracks outcomes among this vulnerable patient population.
Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report
Feb. 5, 2020—Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.
Achilles’ heel for kidney cancer
Feb. 28, 2019—The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.
Rathmell elected to ASCO nominating committee
Dec. 19, 2017—W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee for the American Society of Clinical Oncology (ASCO).
Award-winning VICC investigators in spotlight at ASCO
Jun. 25, 2015—The 2015 Annual Meeting of the American Society of Clinical Oncology, held May 29 - June 2 in Chicago, put multiple Vanderbilt-Ingram Cancer Center investigators in the spotlight.
New VU app takes SMART look at clinical information sharing
Jun. 4, 2015—On June 1 in Chicago, at the annual meeting of the American Society of Clinical Oncology, a mobile computer application under development at Vanderbilt University Medical Center, called SMART Precision Cancer Medicine (PCM), was featured in a demonstration of improved cancer care coordination through clinical data interoperability and electronic clinical information sharing.
Cancer organizations call for regulation of e-cigarettes
Jan. 15, 2015—Two leading cancer organizations are calling for regulation of e-cigarettes and other electronic nicotine delivery systems (ENDS).